Novonesis (Novozymes) B NZM2
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Novonesis (Novozymes) B is the Class B share of Novonesis A/S, a leading biotechnology company headquartered in Lyngby, Denmark. Formed in 2024 through the merger of Novozymes and Chr. Hansen, it holds a dominant near-50% market share in industrial enzymes and microbial solutions worldwide. The company develops and sup…
SectorBasic Materials
ExchangeXETR
IndustrySpecialty Chemicals
CountryDenmark
Employees6,385
TickerNZM2
Statistics
Market Cap$27.88B
Revenue (TTM)$4.92B
Net Income—
Net Margin—
EPS—
P/E39.86
P/S5.66
P/B2.16
EV/EBITDA17.14
ROE5.4%
Dividend Yield1.10%
Price$59.79
Data: Twelve Data · Revenue = mcap / P/S